INO — Inovio Pharmaceuticals Share News
0.000.00%
- $92.76m
- $56.08m
- $0.07m
Brief: Inovio Announces Pricing Of $17.5 Million Public Offering
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Inovio Pharmaceuticals falls as it plans stock and warrant offering
U.S. STOCKS ON THE MOVE-Globalstar, Wingstop, US energy stocks
Inovio falls after suspending stock sale program
Brief: Inovio And Akeso Announce Clinical Collaboration To Advance Novel Combination Therapy For Glioblastoma (Gbm)
U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66
Brief: Inovio Announces Pricing Of $25 Million Public Offering
Inovio Pharma falls on $25 mln stock sale
Brief: Inovio Announces Proposed Public Offering
Inovio Q3 net loss widens on non-cash warrant liabilities
Brief: Inovio Pharmaceuticals Q3 EPS USD -0.87
Brief: Inovio To Begin Rolling Submission Of BLA For Ino-3107 For The Treatment Of RRP In Adults
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Pharmaceuticals Inc expected to post a loss of 61 cents a share - Earnings Preview
Inovio Pharmaceuticals Inc expected to post a loss of 61 cents a share - Earnings Preview
Inovio Pharma plunges on $25 mln stock-and-warrants offering
Inovio Pharma dives on equity offering plans
Brief: Inovio Announces Proposed Public Offering